PS2-11: Validation of KRAS Mutation Testing Across Five Certified Laboratories

KRAS mutation testing helps oncologists decide whether patients diagnosed with metastatic colorectal cancer (CRC) should be treated with epidermal growth factor receptor (EGFR) inhibitors. These drugs block the EGFR signaling pathway in tumor cells, and thus can slow tumor progression. Mutated KRAS...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Feigelson, Heather, Rahm, Alanna Kulchak, Funk, Kellyan, Kauffman, Tia, Johnson, Monique, Richards, Carolyn Sue, LeMarchand, Loic, Goddard, Katrina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Marshfield Clinic 2011
Pynciau:
SELECTED ABSTRACTS - HMORN 2011: Cancer
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251394/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.ps2-11
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg